Effect of C-Reactive Protein–Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia
Elodie von Dach(University Hospital of Geneva), Angela Huttner(University Hospital of Geneva), Shawna McCallin, Clémence Cuvelier, Stephan Harbarth(University Hospital of Geneva), Pierre–Yves Bochud(University of Lausanne), Anne Rossel(University Hospital of Geneva), Benedikt Huttner(World Health Organization), Angèle Gayet‐Ageron, Laurent Kaiser(University Hospital of Geneva), Philipp Köhler(University of St.Gallen), Virginie Prendki(Hôpital Beau-Séjour), Anne-Sophie Brunel(University of Lausanne), Werner C. Albrich(University of St.Gallen), Eva Lemmenmeier(Kantonsspital St. Gallen), Domenica Flury
Cited by 255
Related Papers
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)
|Clinical Microbiology and Infection|2021|1k
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19
|Immunity|2020|409
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293